Aptevo Therapeutics
APVO
APVO
8 hedge funds and large institutions have $5.99M invested in Aptevo Therapeutics in 2021 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
less ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
86% less capital invested
Capital invested by funds: $42.1M → $5.99M (-$36.1M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
8
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.23M | |
| 2 | +$883K | |
| 3 | +$757K | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$364K |
Top Sellers
| 1 | -$27.2M | |
| 2 | -$4.34M | |
| 3 | -$3.26M | |
| 4 |
Renaissance Technologies
New York
|
-$541K |
| 5 |
Franklin Resources
San Mateo,
California
|
-$242K |